Fees delay pharmed drug
Wednesday, April 22, 2009 - 12:15
in Health & Medicine
European trial of 'pharmed' anti-HIV monoclonal delayed by costly regulatory process.
European trial of 'pharmed' anti-HIV monoclonal delayed by costly regulatory process.